Euclises Pharmaceuticals' Angel Round

Euclises Pharmaceuticals raised a round of funding on June 12, 2012. Investors include St. Louis Arch Angels.

Euclises Pharmaceuticals (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio…

Articles about Euclises Pharmaceuticals' Angel Round: